News Sentiment

AUPH sentiment intelligence

Aurinia Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 16.46 Week of 19 Jun 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+4.0% over one week, +8.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Understanding Momentum Shifts in (AUPH)

Market Reaction

Price moving ahead of tone

67/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 4.0% Price confirming higher
Trend fit Trend active 8.1% over four weeks
Fair value 70.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 32
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
Market source 10
simplywall.st 8
TradingKey 3
AD HOC NEWS 3
Stock Traders Daily 2
ChartMill 2
Benzinga 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 14
Deals and strategy 5
Analyst action 4
Balance sheet 2
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
Stock Traders Daily Direct company coverage

Discipline and Rules-Based Execution in AUPH Response

This article analyzes Aurinia Pharmaceuticals Inc (AUPH) using AI models, identifying divergent sentiment across different time horizons. It provides specific trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with entry zones, targets, and stop losses. The

Tone
Positive 60/100
Event
Market update
Published
28 May 2026 17:10
Source
Stock Traders Daily
Simply Wall Street Direct company coverage

AUPH: Future Opportunities Will Depend On Pipeline Clarity And Risk Developments

Aurinia Pharmaceuticals (AUPH) has maintained an analyst consensus target of $17.00, supported by updated model inputs and recent sector deal activity, though some analysts express caution regarding company-specific execution risks. The company recently appointed new executives a

Tone
Neutral 50/100
Event
Analyst action
Published
27 May 2026 20:09
Source
Simply Wall Street
Stock Titan Direct company coverage

Aurinia Pharmaceuticals (AUPH) grants PSUs and stock options to CFO

Aurinia Pharmaceuticals (AUPH) has granted its Chief Financial Officer, Michael S. Hearne, 116,144 performance stock units (PSUs) and 70,230 employee stock options. The PSUs are performance-based, vesting in tranches upon the company's shares reaching specific target prices and t

Tone
Neutral 50/100
Event
Analyst action
Published
21 May 2026 03:39
Source
Stock Titan
Stock Titan Direct company coverage

Aurinia (AUPH) COO receives 116,144 PSUs and 70,230 stock options

Aurinia Pharmaceuticals Inc.'s Chief Operating Officer, Ryan Cole, was granted 116,144 performance stock units (PSUs) and 70,230 stock options. These equity awards are compensation-related, with the PSUs vesting based on share-price targets and time-based conditions, and the stoc

Tone
Neutral 50/100
Event
Market update
Published
20 May 2026 21:09
Source
Stock Titan